Company · CIK 0001601830 · SIC 2836 — Biological Products, (No Diagnostic Substances) · Nasdaq
RECURSION PHARMACEUTICALS, INC. · RXRX
Insider activity reported against this company. All insider holders · On EDGAR ↗
Reported at this company — common stock
| Trade | Reported (ET) | Insider | Shares | Avg price | Total | Owned after | Δ stake | Flags |
|---|---|---|---|---|---|---|---|---|
| Sep 15, 2026 FForm 4 → | Sep 16, 5:52 pm EDT | Ben R TaylorChief Financial Officer | 5,396 | $3.41 | $18,400 | 1,071,462 | — | |
| Sep 8, 2026 SForm 4 → | Sep 10, 5:55 pm EDT | Najat KhanCEO and President, Director | 22,408 | $3.52 | $78,822 | 2,072,890 | −1.07% | 10b5-1 |
| Sep 1, 2026 SForm 4 → | Sep 2, 6:01 pm EDT | Blake BorgesonDirector | 30,000 | $3.34 | $100,200 | 6,158,287 | −0.48% | 10b5-1 |
| Aug 17, 2026 FForm 4 → | Aug 18, 5:44 pm EDT | Najat KhanCEO and President, Director | 80,498 | $3.16 | $254,374 | 2,095,298 | — | |
| Aug 17, 2026 FForm 4 → | Aug 18, 5:44 pm EDT | David HallettChief Scientific Officer | 26,657 | $3.16 | $84,236 | 1,043,837 | — | |
| Aug 17, 2026 FForm 4 → | Aug 18, 5:44 pm EDT | Ben R TaylorChief Financial Officer | 25,018 | $3.16 | $79,057 | 1,076,858 | — | |
| Aug 4, 2026 SForm 4 → | Aug 6, 5:09 pm EDT | Blake BorgesonDirector | 30,000 | $3.25 | $97,500 | 6,188,287 | −0.48% | 10b5-1 |
| Jul 7, 2026 SForm 4 → | Jul 9, 6:04 pm EDT | Blake BorgesonDirector | 40,000 | $3.96 | $158,500 | 6,218,287 | −0.64% | 10b5-1 |
| Jul 1, 2026 AForm 4 → | Jul 2, 5:15 pm EDT | Zavain DarDirector | 5,109 | — | — | 240,764 | — | |
| Jul 1, 2026 AForm 4 → | Jul 2, 5:15 pm EDT | Dean Y LiDirector | 3,747 | — | — | 1,473,329 | — | |
| Jun 18, 2026 SForm 4 → | Jun 22, 4:32 pm EDT | Namandje BumpusDirector | 3,963 | $3.18 | $12,602 | 127,632 | −3.01% | 10b5-1 |
| Jun 17, 2026 AForm 4 → | Jun 22, 4:32 pm EDT | Blake BorgesonDirector | 88,424 | — | — | 6,258,287 | — | |
| Jun 17, 2026 AForm 4 → | Jun 22, 4:32 pm EDT | Robert HershbergDirector | 88,424 | — | — | 162,156 | — | |
| Jun 17, 2026 AForm 4 → | Jun 22, 4:32 pm EDT | Franziska MichorDirector | 88,424 | — | — | 215,477 | — | |
| Jun 17, 2026 AForm 4 → | Jun 22, 4:32 pm EDT | Elaine D SunDirector | 88,424 | — | — | 135,981 | — | |
| Jun 17, 2026 AForm 4 → | Jun 22, 4:32 pm EDT | Zavain DarDirector | 88,424 | — | — | 235,655 | — | |
| Jun 17, 2026 AForm 4 → | Jun 22, 4:32 pm EDT | Dean Y LiDirector | 88,424 | — | — | 1,469,582 | — | |
| Jun 17, 2026 AForm 4 → | Jun 22, 4:32 pm EDT | Namandje BumpusDirector | 88,424 | — | — | 131,595 | — | 10b5-1 |
| Jun 15, 2026 FForm 4 → | Jun 17, 5:07 pm EDT | Ben R TaylorChief Financial Officer | 5,396 | $3.15 | $16,997 | 1,101,876 | — | |
| Jun 5, 2026 SForm 4 → | Jun 5, 5:03 pm EDT | Christopher GibsonDirector | 40,000 | $3.62 | $144,800 | 883,735 | −4.33% | 10b5-1 |
| Jun 5, 2026 CForm 4 → | Jun 5, 5:03 pm EDT | Christopher GibsonDirector | 40,000 | — | — | 923,735 | — | 10b5-1 |
| Jun 5, 2026 SForm 4 → | Jun 5, 5:02 pm EDT | Najat KhanCEO and President, Director | 23,588 | $3.58 | $84,459 | 2,175,796 | −1.07% | 10b5-1 |
| Jun 3, 2026 SForm 4 → | Jun 4, 5:04 pm EDT | Namandje BumpusDirector | 4,386 | $3.54 | $15,526 | 43,171 | −9.22% | 10b5-1 |
| Jun 2, 2026 SForm 4 → | Jun 4, 5:04 pm EDT | Blake BorgesonDirector | 30,000 | $3.68 | $110,400 | 6,169,863 | −0.48% | 10b5-1 |
Reported at this company — derivatives (options, RSUs, warrants)
| Trade | Reported (ET) | Insider | Shares | Avg price | Total | Owned after | Δ stake | Flags |
|---|---|---|---|---|---|---|---|---|
| Jun 5, 2026 CForm 4 → | Jun 5, 5:03 pm EDT | Christopher GibsonDirector | 40,000 | — | — | 4,263,334 | — | 10b5-1 |